What Pipeline Problems? Kindler Gets A Raise
Make a commentBy Ed Silverman // March 14th, 2008 // 11:22 pm
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | 31 | |||||
• Pharma Blog » 2008 » March
Pharmalot March 14th, 2008 Archive
Biosimilar Bill Is Introduced To Hoots & Hollers
2 CommentsBy Ed Silverman // March 14th, 2008 // 8:50 pm
Did Lilly’s New CEO Urge Off-Label Promotion?
22 CommentsBy Ed Silverman // March 14th, 2008 // 5:04 pm
What Setbacks? Wyeth’s Essner Gets A Raise
3 CommentsBy Ed Silverman // March 14th, 2008 // 4:43 pm
NJ Informed Consent Bill Passes Key Hurdle
31 CommentsBy Ed Silverman // March 14th, 2008 // 12:11 pm
Yanai: No ‘Company On The Planet’ Like Teva
1 CommentBy Ed Silverman // March 14th, 2008 // 11:39 am
Taurel: Here Come The ‘Targeted Therapeutics’
Make a commentBy Ed Silverman // March 14th, 2008 // 10:39 am
Zyprexa Label In Japan Was Tougher Than In US
4 CommentsBy Ed Silverman // March 14th, 2008 // 9:35 am
Eyeing Coverage: Ontario Blinks Over Lucentis
2 CommentsBy Ed Silverman // March 14th, 2008 // 8:25 am
Philly Judge Rules ‘No Preemption’ In Paxil Case
9 CommentsBy Ed Silverman // March 14th, 2008 // 7:05 am